Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended 30th September 2026

Date: 02-11-2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Listing Department Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai-400051 Mumbai-400001 Scrip Code: MUKKA Scrip Code: 544135 Dear Sir/Madam Subject: Intimation of Board Meeting. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 7th November 2026, inter alia, to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended 30th September 2026. Further, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of "Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders" of the Company, the trading window for dealing in the securities of the Company is closed with effect from Thursday, 1st October 2026 till 48 hours after the declaration of the said results for the Designated Persons and their immediate relatives (as defined under the aforesaid code of conduct) and the same has been informed to them. This is for your information and records. Thank you, For Mukka Proteins Limited Mehaboobsab Mahmadgous Chalyal Company Secretary & Compliance Officer Membership No.: A67502